Clinical Trials Browser

Phase 1 × INDUSTRY × oregovomab × Clear all

NCT03162562 2020-12-22

The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer

Phase 1 Terminated

Ovarian Neoplasms